tryptophan has been researched along with Thrombocythemia, Essential in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacher, U; Beelen, D; Bojko, P; Bürkle, D; Dengler, R; Distelrath, A; Eckart, M; Eckert, R; Fries, S; Haferlach, C; Haferlach, T; Kern, W; Knoblich, J; Köchling, G; Laubenstein, HP; Petrides, P; Pihusch, R; Planker, M; Schnittger, S; Weide, R | 1 |
Hsiao, HH; Hsu, JF; Lee, CP; Lin, SF; Liu, YC; Tsai, HJ | 1 |
2 other study(ies) available for tryptophan and Thrombocythemia, Essential
Article | Year |
---|---|
Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Mutation; Primary Myelofibrosis; Receptors, Thrombopoietin; Thrombocythemia, Essential; Tryptophan | 2009 |
JAK2V617F mutation is associated with special alleles in essential thrombocythemia.
Topics: Alleles; Amino Acid Substitution; DNA Mutational Analysis; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Humans; Janus Kinase 2; Leucine; Lysine; Mutation, Missense; Phenylalanine; Polymorphism, Single Nucleotide; Receptors, Thrombopoietin; Thrombocythemia, Essential; Tryptophan; Valine | 2011 |